Market Overview:
The global pediatric electrolyte solutions market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of dehydration in children, rising awareness about pediatric electrolyte solutions, and growing demand for oral pediatric electrolyte solutions. Based on type, the global pediatric electrolyte solutions market is segmented into oral and injection segments. The oral segment is expected to account for a larger share of the market than the injection segment during the forecast period. This can be attributed to factors such as ease of use and lower cost as compared to injection pediatric electrolyte solutions. Based on application, the global pediatric electrolyte solutions market is divided into hospital pharmacies, retail pharmacies, and online pharmacies segments.
Product Definition:
A Pediatric Electrolyte Solution is a medical drink used to replace lost fluids and electrolytes in children. It is often prescribed to treat or prevent dehydration, especially in children with diarrhea or vomiting. Pediatric Electrolyte Solutions are also used to correct electrolyte imbalances, such as low potassium or sodium levels.
Oral:
Oral is a route of administration which involves the use of drugs or medication administered in the mouth. The drug or medication can be solid (such as tablets) or liquid (such as syrup). In most cases, oral medications are preferred over parenteral because they are safer and more convenient.
Injection:
Injection is a process through which the electrolyte is introduced into the patient's body. Injection of electrolytes helps in maintaining appropriate fluid balance in patients suffering from diarrhea, vomiting, and other conditions where the normal amount of fluids are lost from the body. It also helps to prevent hypokalemia (low potassium) and hyperkalemia (high potassium).
Application Insights:
Based on application, the global market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high volume of drug dispensing and an increasing number of patients suffering from electrolyte imbalance. In addition, growing investments by pharmaceutical companies for the development of new drugs targeted towards pediatric population are also expected to drive demand over the forecast period.
The retail pharmacy accounted for a significant share owing to rising awareness among parents regarding access to medicines at affordable prices through local retailers rather than through hospitals or other healthcare facilities that dispense expensive medicines without considering affordability factor.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable government initiatives, and increasing awareness among children and their parents about the importance of proper nutrition are some factors responsible for its large share. Moreover, a rise in cases of pediatric chronic diseases is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in R&D activities by leading pharmaceutical companies may also contribute toward regional expansion due to growing demand for nutritional products targeting children aged 1 - 14 years old globally (excluding Japan).
Growth Factors:
- Increasing incidence of chronic diseases in children
- Growing awareness about the benefits of pediatric electrolyte solutions
- Rising demand for pediatric electrolyte solutions from emerging markets
- Technological advancements in pediatric electrolyte solutions industry
- increasing number of mergers and acquisitions in the pediatric electrolyte solutions market
Scope Of The Report
Report Attributes
Report Details
Report Title
Pediatric Electrolyte Solutions Market Research Report
By Type
Oral, Injection
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Abbott Nutrition, Mead Johnson, Pendopharm, Johnson & Johnson, Jiangsu Hengrui Medicine, Otsuka Pharmaceutical Factory, Watson Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Pediatric Electrolyte Solutions Market Report Segments:
The global Pediatric Electrolyte Solutions market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Nutrition
- Mead Johnson
- Pendopharm
- Johnson & Johnson
- Jiangsu Hengrui Medicine
- Otsuka Pharmaceutical Factory
- Watson Pharma
Highlights of The Pediatric Electrolyte Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pediatric Electrolyte Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pediatric Electrolyte Solutions (PES) are a type of intravenous fluid that is used to hydrate children who are hospitalized or have surgery. PES contain sodium, potassium, chloride, and bicarbonate.
Some of the key players operating in the pediatric electrolyte solutions market are Abbott Nutrition, Mead Johnson, Pendopharm, Johnson & Johnson, Jiangsu Hengrui Medicine, Otsuka Pharmaceutical Factory, Watson Pharma.
The pediatric electrolyte solutions market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pediatric Electrolyte Solutions Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pediatric Electrolyte Solutions Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pediatric Electrolyte Solutions Market - Supply Chain
4.5. Global Pediatric Electrolyte Solutions Market Forecast
4.5.1. Pediatric Electrolyte Solutions Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pediatric Electrolyte Solutions Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pediatric Electrolyte Solutions Market Absolute $ Opportunity
5. Global Pediatric Electrolyte Solutions Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pediatric Electrolyte Solutions Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pediatric Electrolyte Solutions Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pediatric Electrolyte Solutions Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pediatric Electrolyte Solutions Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pediatric Electrolyte Solutions Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pediatric Electrolyte Solutions Demand Share Forecast, 2019-2026
9. North America Pediatric Electrolyte Solutions Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pediatric Electrolyte Solutions Demand Share Forecast, 2019-2026
10. Latin America Pediatric Electrolyte Solutions Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pediatric Electrolyte Solutions Demand Share Forecast, 2019-2026
11. Europe Pediatric Electrolyte Solutions Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pediatric Electrolyte Solutions Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Injection
11.8. Basis Point Shar (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pediatric Electrolyte Solutions Demand Share, 2019-2026
12. Asia Pacific Pediatric Electrolyte Solutions Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pediatric Electrolyte Solutions Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pediatric Electrolyte Solutions Demand Share, 2019-2026
13. Middle East & Africa Pediatric Electrolyte Solutions Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pediatric Electrolyte Solutions Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pediatric Electrolyte Solutions Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pediatric Electrolyte Solutions Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pediatric Electrolyte Solutions Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pediatric Electrolyte Solutions Market: Market Share Analysis
14.2. Pediatric Electrolyte Solutions Distributors and Customers
14.3. Pediatric Electrolyte Solutions Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Nutrition
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mead Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pendopharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Jiangsu Hengrui Medicine
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Otsuka Pharmaceutical Factory
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Watson Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
